Lin Huang

3.6k citations
109 papers · 2.7k indexed · 1 hit paper · h-index 30

Lin Huang

103 papers receiving 2.6k citations

Hit Papers

NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-...202320262024202520234080120

Peers

Lin Huang
Comparison fields: 5 of 119
  • Molecular Biology 1.6k
  • Immunology 546
  • Genetics 261
  • Epidemiology 209
  • Oncology 201
Replace David C. Parmelee with:
David C. Parmelee United States
Mary E. McGrath United States
Peter Mose Larsen Denmark
Ineo Ishizuka Japan
H.P. Kocher Switzerland
Yanbao Yu United States
Shinji Yoshitake Japan
Mads Daugaard Canada
Ute Fischer Germany
Erik Fries Sweden
Lin Huang relative to David C. Parmelee United States David C. Parmelee's profile →
Citations per field
00.5×12.1×
David C. Parmelee · 1×
Citations per year

Countries citing papers authored by Lin Huang

Since Specialization
Citations

This map shows the geographic impact of Lin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Huang more than expected).

Fields of papers citing papers by Lin Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Huang. The network helps show where Lin Huang may publish in the future.

Co-authorship network of co-authors of Lin Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Huang. A scholar is included among the top collaborators of Lin Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Huang. Lin Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 0
5 17
6 5
7 5
8 9
9 8
10 3
11 18
12
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancerbreakdown →
128
13 6
14 14
15 17
16 32
17 20
18 110
19 7
20 3

About Lin Huang

Lin Huang is a scholar working on Immunology, Molecular Biology and Structural Biology, having authored 109 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (40 papers), RNA modifications and cancer (34 papers) and RNA Research and Splicing (24 papers). The work is most often cited by research in Immunology (546 citations), Molecular Biology (1.6k citations) and Cancer Research (187 citations). Lin Huang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include David M.J. Lilley, Ian Nicholas Crispe, Robert A. Bambara, John J. Turchi, Richard S. Murante, Jia Wang, Richard A. Flavell, Gloria Soldevila, Yoonhee Kim and James P. Morgan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026